Simvastatin
Product Images NDC 53808-1078

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 53808-1078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 40mg (40mg Blu Pharm)

This is a description of a medication called Simvastatin. It comes in 40mg tablets and there are 30 tablets in the bottle/package (QRy: 30). The medication was manufactured by a company named BLUPHARM, lot number 138025128, and was packaged by DOH Central Pharmacy. There are also other details related to the lot number and the expiration date (05-04-2014).*

FDA Label Image

Label Image For 5mg (5mg Blu Caribe)

FDA Label Image

Label Image For 10mg (Simvastatin 10mg)

This is a medication called Simvastatin, which comes in 10mg tablets. The label indicates that it is available only with a prescription and was supplied by the Central Pharmacy in Tallahassee, Florida. The lot number and expiration date are also provided, but the rest of the text is not very clear due to errors.*

FDA Label Image

Figure 1 (Simvastatin 1)

This text provides information on drug interactions that could lead to a higher risk of myopathy/rhabdomyolysis. The interacting agents listed are strong CYP3A4 inhibitors, verapamil, amiodarone and grapefruit juice. The text provides prescribing recommendations and contraindications for simvastatin when used with these agents, such as avoiding grapefruit juice and not exceeding certain daily doses of simvastatin.*

FDA Label Image

Figure 9 (Simvastatin 10)

FDA Label Image

Figure 2 (Simvastatin 2)

This is a table presenting the adverse reactions reported by 32% of patients treated with Simvastatin. The table shows various disorders and their frequency compared to a placebo. It is not possible to fully interpret the data without the complete table.*

FDA Label Image

Structure (Simvastatin 3)

FDA Label Image

Figure 3 (Simvastatin 4)

FDA Label Image

Table 4 (Simvastatin 5)

FDA Label Image

Figure 5 (Simvastatin 6)

FDA Label Image

Figure 6 (Simvastatin 7)

FDA Label Image

Figure 7 (Simvastatin 8)

FDA Label Image

Figure 8 (Simvastatin 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.